Navigation Links
Study: Tropical wetlands hold more carbon than temperate marshes
Date:10/8/2008

COLUMBUS, Ohio In one of the first comparisons of its kind, researchers have demonstrated that wetlands in tropical areas are able to absorb and hold onto about 80 percent more carbon than can wetlands in temperate zones.

The scientists extracted soil cores from wetlands in Costa Rica and in Ohio and analyzed the contents of the sediment from the past 40 years. Based on their analysis, they estimated that the tropical wetland accumulated a little over 1 ton of carbon per acre per year, and the temperate wetland accumulated .6 tons of carbon per acre per year.

The temperate Ohio wetland in the study covers almost 140 acres, meaning it sequesters 80 tons of carbon per year. The tropical wetland covers nearly 290 acres and stores 300 tons of carbon each year.

"Finding out how much carbon has accumulated over a specific time period gives us an indication of the average rate of carbon sequestration, telling us how valuable each wetland is as a carbon sink," said William Mitsch, senior author of the study and an environment and natural resources professor at Ohio State University. "We already know wetlands are outstanding coastal protection systems, and yet wetlands continue to be destroyed around the planet. Showing that wetlands are gigantic carbon sequestration machines might end up being the most convincing reason yet to preserve them."

Mitsch, also director of the Wilma H. Schiermeier Olentangy River Wetland Research Park at Ohio State, conducted the study with graduate student Blanca Bernal, who presented a poster on this research Wednesday (10/8) at the Geological Society of America joint meeting in Houston.

Often called the "kidneys" of the environment, wetlands act as buffer zones between land and waterways. In addition to absorbing carbon and holding onto it for years, wetlands filter out chemicals in water that runs off from farm fields, roads, parking lots and other surfaces.

But wetlands are also a n
'/>"/>

Contact: William Mitsch
Mitsch.1@osu.edu
614-292-9774
Ohio State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study: diabetic neuropathy costs billions per year in lost work time
2. Study: Fountain of youth for your heart?
3. First-ever study: lack of critical lubricant causes wear in joints
4. Mayo Clinic study: Ossurs collars superior in immobilization and reduction of pressure
5. Study: weight-loss tips differ in African-American, mainstream magazines
6. Smithsonian study: Sediment prediction tools off the mark
7. Mouse study: When it comes to living longer, its better to go hungry than go running
8. Geisinger study: Inflammatory disease causes blindness
9. Stanford study: Bioenergy potential of reviving abandoned agricultural land
10. U-M study: Herceptin targets breast cancer stem cells
11. Study: Future snowmelt in West twice as early as expected; threatens ecosystems and water reserves

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...e of butterfly wings has inspired a 3.2m, three-ye...ation in the fields of security, energy and the en...nal technology company QinetiQ have just signed a ... based on groundbreaking physical sciences researc...ists from the University of Exeter and QinetiQ wil...
(Date:11/9/2009)...rlands, November 09, 2009 / b3c newswire / - To...and Seventh Wave, an American organization for con...companies have signed a letter of intent with rega...els TIM. The letter of intent proposes a collabora...tems for commercialization in North America. The T...
(Date:11/9/2009)...cientists and industry leaders from around the wor... AACR-NCI-EORTC Molecular Targets and Cancer Thera...re groundbreaking information on important cancer ...x disease and to treat it effectively we need a gr...ce at the molecular level," said Lewis Cantley, Ph...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Take A Swing Against Breast Cancer 21 51913 1Take A Swing Against Breast Cancer 21 51913 2ANDRES F ALONSO ESQ a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP Was Appointed Co Lead Counsel to the Plaintiffs Steering Committee in 51908 1ANDRES F ALONSO ESQ a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP Was Appointed Co Lead Counsel to the Plaintiffs Steering Committee in 51908 2Mettler Toledo International Inc to Host Second Quarter 2009 Earnings Conference Call 51904 1
...NY, October 30, 2008 Bayhill Therapeutics, Inc., ...seases, and the Juvenile Diabetes Research Foundat... 1 diabetes research, today announced a partnershi...inical trial of BHT-3021, a DNA vaccine to reverse..., BHT-3021 is an antigen-specific immunotherapeut...
...raits that we look for typically include a sense o...isma. However, a recent study suggests that it is ...cation skills that determine who is chosen as lead...at there is a gender bias when selecting leaders; ...end on the specific situation that a group finds i...
...rs at Georgetown University Medical Center have di...become resistant to tamoxifen, the world,s largest...ug. They say the findings could provide a way to i...ng from the drug, allowing doctors to try another ...f the journal Cancer Research, the researchers s...
Other Biology News:Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 2Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 3Gender biases in leadership selection during competitions within and between groups 2Gender biases in leadership selection during competitions within and between groups 3'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
(Date:11/9/2009)...wswire-USNewswire/ -- The Appignani Bioethics Cent..., held a panel discussion today at the National Pr...ogies in biomedical sciences and climate change. T...w Light, both of the Center for American Progress,...cal angles. ,, A video of the event will be ma...
(Date:11/9/2009)...Newswire-Asia/ -- The pharma and biotech sectors a...panies are facing significant,pressure to change w..., calls for,lower prices and a greater regulatory ...al crisis have made the work of creating new drugs...e being forced to globalize their R&D,operatio...
(Date:11/9/2009)...PRNewswire/ -- Following the provision of clinical...istration (FDA), privately,owned UK company Daval ...nal.com ) has been informed that its innovative,an...an Orphan-Drug,designation for the treatment of Am... also known as Lou Gehrig,s disease, is the most c...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- BioSpecifics Technologies...ny developing first-in-class collagenase-based pro...he third quarter ended September 30, 2009. ,, ...s year, the FDA,s Arthritis Advisory Committee una...val of XIAFLEX(TM) for the treatment of Dupuytren,...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...n of the Board -, MADISON, N.J., April 24 Wyeth ...obert Essner, 60, has decided to retire,from the C...d the position,of Chairman since January 2003 and ...1 to 2007. The Company,s Board of Directors has el... Executive Officer, to the,additional position of ...
...Inc.,(Nasdaq: HOLX ), a diversified medical techn...imaging products and interventional devices dedica...y announced plans to release its,second quarter fi...08 at,8:00 a.m. (eastern). In conjunction with the...n Thursday, May 1, 2008 at 9:00 a.m. (eastern)., ...
...ewswire-FirstCall/ -- China Sky One,Medical, Inc. ...lletin,Board: CSKI), a pharmaceutical company for ...s Republic of China ("PRC"), today announced it,ac...ina Pharmaceutical"), a,recently formed corporatio... 2008., China Sky One Medical, Inc., through its ...
Other Biology Technology:Wyeth Chairman Robert Essner Announces June 27 Retirement 2Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 3
Mouse Anti-Human LAT, phospho (Tyr226) Monoclonal Antibody, Unconjugated, Clone J96-1238.58.93 from BD Biosciences Pharmingen
TE Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade from Research Organics, Inc.
...t-effective solution to your TechMate Detection re...lity into both our products and service capabiliti... antibodies that have been optimized to the TechMa...iced accessories that can be purchased individuall...
PAP PEN from Invitrogen
Biology Products: